Editorial in response to: PET/CT evaluation of 18F-FDG uptake in pericoronary adipose tissue in patients with stable coronary artery disease: Independent predictor of atherosclerotic lesion formation? | springermedicine.com

Springer Medicine

Top

Journal of Nuclear Cardiology

Published in:

01-06-2017 | Editorial

Editorial in response to: PET/CT evaluation of ¹⁸F-FDG uptake in pericoronary adipose tissue in patients with stable coronary artery disease: Independent predictor of atherosclerotic lesion formation?

Is there prognostic value in evaluation of 18F-FDG uptake in the pericoronary adipose tissue?

Authors: Stephanie L. Thorn, PhD, Albert J. Sinusas, MD

Published in: Journal of Nuclear Cardiology | Issue 3/2017

Login to get access

Excerpt

Atherosclerosis is a chronic progressive disease that can lead to ischemic heart disease or cerebrovascular stroke, two of the worlds’ leading causes of death.1 Atherosclerosis involves a complex process, and is driven by a cyclic inflammatory response initiated by deposition of low density lipoprotein within arterial walls. Therefore, inflammation is one of the key modulators of plaque development and can lead to plaque rupture or erosion.2 Recent investigative efforts have focused on technologies and subsequent methodologies that not only detect atherosclerotic plaque and assess the severity of a stenosis, but also attempt to identify the features associated with plaque instability. …

1.

Mortality GBD. Causes of Death C. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the global burden of disease study 2013. Lancet 2015;385:117–71.CrossRef

2.

Zimarino M, Prati F, Marano R, Angeramo F, Pescetelli I, Gatto L, et al. The value of imaging in subclinical coronary artery disease. Vascul Pharmacol 2016;. doi:10.1016/j.vph.2016.02.001.PubMed

3.

Niccoli G, Liuzzo G, Montone RA, Crea F. Advances in mechanisms, imaging and management of the unstable plaque. Atherosclerosis 2014;233:467–77.CrossRefPubMed

4.

Koskinas KC, Ughi GJ, Windecker S, Tearney GJ, Raber L. Intracoronary imaging of coronary atherosclerosis: Validation for diagnosis, prognosis and treatment. Eur Heart J 2016;37:524–35.CrossRefPubMed

5.

Tavakoli S, Vashist A, Sadeghi MM. Molecular imaging of plaque vulnerability. J Nucl Cardiol 2014;21:1112–28 (quiz 1129).CrossRefPubMedPubMedCentral

6.

Lederman RJ, Raylman RR, Fisher SJ, Kison PV, San H, Nabel EG, et al. Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG). Nucl Med Commun 2001;22:747–53.CrossRefPubMed

7.

Rudd JH, Myers KS, Bansilal S, Machac J, Rafique A, Farkouh M, et al. (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: Implications for atherosclerosis therapy trials. J Am Coll Cardiol 2007;50:892–6.CrossRefPubMed

8.

Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, et al. Imaging atherosclerotic plaque inflammation with [18f]-fluorodeoxyglucose positron emission tomography. Circulation 2002;105:2708–11.CrossRefPubMed

9.

Tawakol A, Migrino RQ, Bashian GG, Bedri S, Vermylen D, Cury RC, et al. In vivo 18f-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006;48:1818–24.CrossRefPubMed

10.

Pedersen SF, Graebe M, Fisker Hag AM, Hojgaard L, Sillesen H, Kjaer A. Gene expression and 18FDG uptake in atherosclerotic carotid plaques. Nucl Med Commun 2010;31:423–9.PubMed

11.

Graebe M, Pedersen SF, Borgwardt L, Hojgaard L, Sillesen H, Kjaer A. Molecular pathology in vulnerable carotid plaques: Correlation with [18]-fluorodeoxyglucose positron emission tomography (fdg-pet). Eur J Vasc Endovasc Surg 2009;37:714–21.CrossRefPubMed

12.

Gholami S, Salavati A, Houshmand S, Werner TJ, Alavi A. Assessment of atherosclerosis in large vessel walls: A comprehensive review of fdg-pet/ct image acquisition protocols and methods for uptake quantification. J Nucl Cardiol 2015;22:468–79.CrossRefPubMed

13.

Qazi AH, Zallaghi F, Torres-Acosta N, Thompson RC, O’Keefe JH. Computed tomography for coronary artery calcification scoring: Mammogram for the heart. Prog Cardiovasc Dis 2016;. doi:10.1016/j.pcad.2016.01.007.PubMed

14.

Motoyama S, Kondo T, Sarai M, Sugiura A, Harigaya H, Sato T, et al. Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol 2007;50:319–26.CrossRefPubMed

15.

Motoyama S, Sarai M, Harigaya H, Anno H, Inoue K, Hara T, et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol 2009;54:49–57.CrossRefPubMed

16.

Marwan M, Achenbach S. Quantification of epicardial fat by computed tomography: Why, when and how? J Cardiovasc Comput Tomogr 2013;7:3–10.CrossRefPubMed

17.

Nakazato R, Dey D, Cheng VY, Gransar H, Slomka PJ, Hayes SW, et al. Epicardial fat volume and concurrent presence of both myocardial ischemia and obstructive coronary artery disease. Atherosclerosis 2012;221:422–6.CrossRefPubMed

18.

Mahabadi AA, Lehmann N, Kalsch H, Robens T, Bauer M, Dykun I, et al. Association of epicardial adipose tissue with progression of coronary artery calcification is more pronounced in the early phase of atherosclerosis: Results from the Heinz Nixdorf recall study. JACC Cardiovasc Imaging 2014;7:909–16.CrossRefPubMed

19.

Maurovich-Horvat P, Kallianos K, Engel LC, Szymonifka J, Fox CS, Hoffmann U, et al. Influence of pericoronary adipose tissue on local coronary atherosclerosis as assessed by a novel MDCT volumetric method. Atherosclerosis 2011;219:151–7.CrossRefPubMedPubMedCentral

20.

Gauss S, Klinghammer L, Steinhoff A, Raaz-Schrauder D, Marwan M, Achenbach S, et al. Association of systemic inflammation with epicardial fat and coronary artery calcification. Inflamm Res 2015;64:313–9.CrossRefPubMed

21.

Maurovich-Horvat P, Kallianos K, Engel LC, Szymonifka J, Schlett CL, Koenig W, et al. Relationship of thoracic fat depots with coronary atherosclerosis and circulating inflammatory biomarkers. Obesity 2015;23:1178–84.CrossRefPubMedPubMedCentral

22.

Gorter PM, de Vos AM, van der Graaf Y, Stella PR, Doevendans PA, Meijs MF, et al. Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography. Am J Cardiol 2008;102:380–5.CrossRefPubMed

23.

Hell MM, Achenbach S, Schuhbaeck A, Klinghammer L, May MS, Marwan M. Ct-based analysis of pericoronary adipose tissue density: Relation to cardiovascular risk factors and epicardial adipose tissue volume. J Cardiovasc Comput Tomogr 2016;10:52–60.CrossRefPubMed

24.

Carrascosa P, Deviggiano A, Leipsic JA, Capunay C, De Zan MC, Goldsmit A, et al. Dual energy imaging and intracycle motion correction for ct coronary angiography in patients with intermediate to high likelihood of coronary artery disease. Clin Imaging 2015;39:1000–5.CrossRefPubMed

25.

Carrascosa P, Deviggiano A, Capunay C, De Zan MC, Goldsmit A, Rodriguez-Granillo GA. Effect of intracycle motion correction algorithm on image quality and diagnostic performance of computed tomography coronary angiography in patients with suspected coronary artery disease. Acad Radiol 2015;22:81–6.CrossRefPubMed

26.

Saam T, Rominger A, Wolpers S, Nikolaou K, Rist C, Greif M, et al. Association of inflammation of the left anterior descending coronary artery with cardiovascular risk factors, plaque burden and pericardial fat volume: A pet/ct study. Eur J Nucl Med Mol Imaging 2010;37:1203–12.CrossRefPubMed

27.

Ben-Haim S, Kupzov E, Tamir A, Israel O. Evaluation of 18f-fdg uptake and arterial wall calcifications using 18f-fdg pet/ct. J Nucl Med 2004;45:1816–21.PubMed

28.

Bural GG, Torigian DA, Chamroonrat W, Houseni M, Chen W, Basu S, et al. Fdg-pet is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging 2008;35:562–9.CrossRefPubMed

29.

Awan Z, Genest J. Inflammation modulation and cardiovascular disease prevention. Eur J Prev Cardiol 2015;22:719–33.CrossRefPubMed

30.

Tousoulis D, Oikonomou E, Economou EK, Crea F, Kaski JC. Inflammatory cytokines in atherosclerosis: Current therapeutic approaches. Eur Heart J 2016. doi:10.1093/eurheartj/ehv759.PubMed

Title: Editorial in response to: PET/CT evaluation of 18F-FDG uptake in pericoronary adipose tissue in patients with stable coronary artery disease: Independent predictor of atherosclerotic lesion formation?
Is there prognostic value in evaluation of 18F-FDG uptake in the pericoronary adipose tissue?
Authors: Stephanie L. Thorn, PhD
Albert J. Sinusas, MD
Publication date: 01-06-2017
Publisher: Springer US
Published in: Journal of Nuclear Cardiology / Issue 3/2017
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI: https://doi.org/10.1007/s12350-016-0458-7

Home
Congress Coverage
Clinical Collections
- Advances in Alzheimer’s
About Springer Medicine
Key Specialties